Sarepta Therapeutics (SRPT) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.11% |
| Dec 31, 2025 | -33.97% |
| Sep 30, 2025 | -1.95% |
| Jun 30, 2025 | 10.65% |
| Mar 31, 2025 | 36.77% |
| Dec 31, 2024 | 17.15% |
| Sep 30, 2024 | 31.63% |
| Jun 30, 2024 | 11.82% |
| Mar 31, 2024 | 14.81% |
| Dec 31, 2023 | -1.18% |
| Sep 30, 2023 | 8.11% |
| Jun 30, 2023 | 15.54% |
| Mar 31, 2023 | -4.86% |
| Dec 31, 2022 | 15.35% |
| Sep 30, 2022 | 60.83% |
| Jun 30, 2022 | 25.89% |
| Mar 31, 2022 | 4.45% |
| Dec 31, 2021 | -5.41% |
| Sep 30, 2021 | 61.54% |
| Jun 30, 2021 | 69.68% |
| Mar 31, 2021 | 78.47% |
| Dec 31, 2020 | 92.41% |
| Sep 30, 2020 | 85.66% |
| Jun 30, 2020 | 97.56% |
| Mar 31, 2020 | 76.53% |
| Dec 31, 2019 | 40.62% |
| Sep 30, 2019 | -5.43% |
| Jun 30, 2019 | 29.87% |
| Mar 31, 2019 | 25.01% |
| Dec 31, 2018 | 101.51% |
| Sep 30, 2018 | 72.20% |
| Jun 30, 2018 | 82.81% |
| Mar 31, 2018 | 322.84% |
| Sep 30, 2017 | 88.59% |
| Jun 30, 2017 | 84.58% |
| Mar 31, 2017 | 246.03% |
| Dec 31, 2016 | 70.04% |
| Sep 30, 2016 | 23.11% |
| Jun 30, 2016 | -1.37% |
| Mar 31, 2016 | 38.77% |
| Dec 31, 2015 | 39.69% |
| Sep 30, 2015 | 31.84% |